Vampa Maria Luisa, Norman Paul J, Burnapp Lisa, Vaughan Robert W, Sacks Steven H, Wong Wilson
Department of Nephrology and Transplantation, Guy's Hospital, London, United Kingdom.
Transplantation. 2003 Oct 27;76(8):1220-8. doi: 10.1097/01.TP.0000083896.91215.C7.
Natural killer (NK) cells use killer immunoglobulin-like receptors (KIR) that bind to self-class I major histocompatibility complex (MHC) molecules to prevent killing of autologous cells. Mismatched allografts, which do not express recipient MHC class I molecules, can therefore be potential targets for NK-cell killing. In our living related-unrelated renal transplantation program, donor-recipient pairs vary in the amount of both HLA and KIR genes they share. This provides us with a unique opportunity to dissect the influence of KIR on NK-cell function after transplantation.
Recipient NK cells were used in a cytotoxicity assay against donor peripheral blood mononuclear cells 2 days before, on the day of, and 3 days after transplantation. Results were correlated to HLA-KIR compatibility between donor and recipient.
NK killing, in a direct ex vivo setting, was demonstrated to be HLA mismatch dependent. Recipient NK antidonor cytotoxicity was unaltered despite having received 2 days' treatment with cyclosporine A before transplantation. However, cytotoxicity increased 3 days after transplantation in 71% of recipients. Recipients exhibiting increased NK cytotoxicity against their donors after transplantation were found to possess more activating KIR genes specific for donor class I MHC molecules than those in whom killing activity did not increase (P<0.04).
NK cells are activated after transplantation despite quadruple immunosuppression, suggesting that recipient NK-cell cytotoxicity against the donor may be a previously unrecognized area of the rejection process, especially in poorly matched donor-recipient pairs where the recipient may not express the correct repertoire of inhibitory receptors to prevent killing of donor cells.
自然杀伤(NK)细胞利用杀伤性免疫球蛋白样受体(KIR)与自身I类主要组织相容性复合体(MHC)分子结合,以防止自体细胞被杀伤。因此,不表达受体MHC I类分子的不匹配同种异体移植物可能成为NK细胞杀伤的潜在靶标。在我们的活体非亲属肾移植项目中,供体 - 受体对在他们共享的HLA和KIR基因数量上存在差异。这为我们提供了一个独特的机会来剖析KIR对移植后NK细胞功能的影响。
在移植前2天、移植当天和移植后3天,使用受体NK细胞对供体外周血单个核细胞进行细胞毒性测定。结果与供体和受体之间的HLA - KIR相容性相关。
在直接的体外实验中,NK杀伤被证明依赖于HLA不匹配。尽管在移植前接受了2天的环孢素A治疗,但受体NK对供体的细胞毒性未改变。然而,71%的受体在移植后3天细胞毒性增加。发现移植后对供体NK细胞毒性增加的受体比杀伤活性未增加的受体拥有更多针对供体I类MHC分子的激活KIR基因(P<0.04)。
尽管进行了四联免疫抑制,NK细胞在移植后仍被激活,这表明受体NK细胞对供体的细胞毒性可能是排斥反应过程中一个以前未被认识的领域,特别是在供体 - 受体匹配不佳的情况下,受体可能没有表达正确的抑制性受体库来防止供体细胞被杀伤。